GRACE LEE RAJA M.D. NPI 1558561126

NPI Details

Grace Lee Raja, M.D. is a hematology and oncology internal medicine in Little Rock, AR with 19 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Grace Lee Raja, M.D. NPI is 1558561126. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:2007

The provider's business location address is:

8901 CARTI WAY
LITTLE ROCK, AR
ZIP 72205-523
Phone: (501) 906-3000
Fax: (501) 907-8367

The NPI 1558561126 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Unclassified drugs (HCPCS:J3490)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Magnesium level (HCPCS:83735)
• Folic acid level, serum (HCPCS:82746)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Blood test, clotting time (HCPCS:85610)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Protein measurement, serum (HCPCS:84165)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Drawing of blood for a medical problem (HCPCS:99195)
• Nephelometry, test method using light (HCPCS:83883)
• Blood creatinine level (HCPCS:82565)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection of drug or substance into vein (HCPCS:96374)
• Uric acid level, blood (HCPCS:84550)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Vitamin d-3 level (HCPCS:82306)
• Phosphate level (HCPCS:84100)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 7/23/2007 and was last updated on 3/10/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: